A quick rundown aimed at people just starting GLP-1 treatment, covering the changes they might notice and ways to get ready for them.
Recap by typeshit. Post by Facebook on Facebook.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Newsweek points to research showing patients can put lost weight back on quickly once they come off GLP-1 drugs.
Wegovy is semaglutide acting on GLP-1, while Mounjaro is tirzepatide acting on both GIP and GLP-1. A short social post breaks down the difference.
Loading…